Dose-volumetric Parameters for Predicting Severe Radiation Pneumonitis after Three-dimensional Conformal Radiation Therapy for Lung Cancer-Reference-Cited by-同舟云学术

Dose-volumetric Parameters for Predicting Severe Radiation Pneumonitis after Three-dimensional Conformal Radiation Therapy for Lung Cancer

Published:2005-04 Issue:1 Volume:235 Page:208-215
ISSN:0033-8419
Container-title:Radiology
language:en
Short-container-title:Radiology

Author:

Kim Tae Hyun,Cho Kwan Ho,Pyo Hong Ryull,Lee Jin Soo,Zo Jae Ill,Lee Dae Ho,Lee Jong Mog,Kim Hyae Young,Hwangbo Bin,Park Sung Yong,Kim Joo Young,Shin Kyung Hwan,Kim Dae Yong

Publisher

Radiological Society of North America (RSNA)

Subject

Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/radiol.2351040248

Reference41 articles.

1. Partial irradiation of the lung

2. Tolerance of normal tissue to therapeutic irradiation

3. Dose escalation for non-small cell lung cancer using conformal radiation therapy

4. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis

5. Kwa SL, Lebesque JV, Theuws JC, et al.Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.Int J Radiat Oncol Biol Phys1998; 42:1-9.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of proton therapy for non-small cell lung cancer in patients with interstitial pneumonia;Radiation Oncology;2022-03-21

2. Adaptive radiation therapy (art) for patients with limited-stage small cell lung cancer (LS-SCLC): A dosimetric evaluation;Indian Journal of Cancer;2022

3. Analysis of the planned, delivered dose distributions and quality assurance for helical tomotherapy and volumetric modulated arc therapy in locally advanced non-small cell lung cancer;Reports of Practical Oncology and Radiotherapy;2021-12-30

4. Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients;Radiation Oncology;2021-11-14

5. Risk factor of pneumonitis on dose-volume relationship for chemoradiotherapy with durvalumab: Multi-institutional research in Japan;Clinical and Translational Radiation Oncology;2021-07